These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Allogeneic bone marrow transplantation for the treatment of Bruton disease].
    Author: Huang X, Shi H, Guo N, Lu D.
    Journal: Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):528-30. PubMed ID: 12482350.
    Abstract:
    OBJECTIVE: To explore the efficacy of allogeneic bone marrow transplantation (allo-BMT) for the treatment of Bruton disease. METHODS: HLA-matched sibling bone marrow transplantation was performed for the treatment of 2 cases of X-linked agammaglobulinemia. One of them received allo-BMT twice. RESULTS: Recovery of hematopoiesis was gained at day 20 and day 13 after allo-BMT in the two cases respectively. Serum immunoglobin rose gradually to normal level in three months. Their humoral immuno-system was reconstituted and life quality improved. These two patients are still in disease-free survival for 13 and 2 years respectively. There was no serious graft-versus-host-disease. CONCLUSION: Stem cell transplantation is a choice for the treatment of Bruton disease.
    [Abstract] [Full Text] [Related] [New Search]